Skip to content
Live newsroom
Tuesday, August 4, 2026 Live Sync: 5 hours ago
Business and future technology newspaper
Business. Innovation. Tomorrow.
BreakingManufacturing survey shows inflation worries 'worse than pandemic era,' adding to Fed pressure
Important

AstraZeneca Shares Sink 7% On $400 Billion Bristol Myers Buyout Talks

AstraZeneca investors questioned the benefits of a potential Bristol Myers Squibb merger despite expected gains in the US market and cost synergies. Source: Read the original article on www.ndtvprofit.com

By deepak · August 3, 2026 · 1 min read

AstraZeneca investors questioned the benefits of a potential Bristol Myers Squibb merger despite expected gains in the US market and cost synergies.

Source: Read the original article on www.ndtvprofit.com